Two Researchers From Kazakh National Medical University Will Train at the Buck Institute
January 3, 2013/Novato, California This coming fall, two scientists from Kazakh National Medical University (KazNMU) will come to the Buck Institute to study the connection between aging and chronic disease. The university will fund the training program which will also involves Buck scientists serving as adjunct faculty at the KazNMU campus located in Almaty. At some point, the Kazakh government hopes to establish an aging research facility at KazNMU with the Buck Institute playing a major role in planning and collaborating on research aimed at preventing and treating age-related disease.
Kazakhstan, once part of the Soviet Union, is more forward-thinking than most other countries when it comes to tackling age-associated chronic diseases. President Nursultan Nazarbayev has challenged the country’s scientists to excel in anti-aging medicine and has made the pursuit of treatments to extend healthspan a national priority. Dr. Aikan Akanov, the Rector of KazNMU, signed the agreement with the Buck Institute.
“I am very excited to get this training program off the ground and to encourage its growth,” said Buck President and CEO Brian Kennedy, PhD, who has worked with Joseph Antoun, MD, Buck Adjunct Professor of Health and Public Policy, to set up the program. “Aging is a global issue and the Buck is committed to be a global player in efforts aimed at forestalling the maladies associated with growing older,” he said. “I congratulate officials in Kazakhstan for their innovative approach and I look forward to working with them in the years ahead.”
About the Buck Institute for Research on Aging
The Buck Institute is the U.S.’s first and foremost independent research organization devoted to Geroscience – the study of the connection of normal aging and chronic disease. Based in Novato, California, the Buck is dedicated to extending “healthspan”, the healthy years of human life, and does so utilizing a unique interdisciplinary approach involving laboratories studying the mechanisms of aging and those focused on specific diseases. Buck scientists strive to discover new ways of detecting, preventing and treating age-related conditions such as Alzheimer’s and Parkinson’s diseases, cancer, cardiovascular disease, macular degeneration, osteoporosis, diabetes and stroke. In their collaborative research, they are supported by the most recent developments in genomics, proteomics, stem cell technology, and bioinformatics. For more information: www.thebuck.org.